Come up with a name for your new list and we'll add to it:
UrSure raised a round of funding on July 12, 2017. Investors include
Harvard Venture Incubation Program.
UrSure is working on a way to increase adherence to the HIV preventive medication, PrEP, by making easy-to-use urine tests that enable physicians to track patient compliance to the drug.…